Log In
Print
BCIQ
Print
Print this Print this
 

SAR245409, XL765

  Manage Alerts
Collapse Summary General Information
Company Exelixis Inc.
DescriptionOral dual inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase
Molecular Target Phosphoinositide 3-kinase (PI3K) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today